ResearcherNational University of SingaporeNo recent work listed

Kanjoormana Aryan Manu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-4437-6486; OpenAlex author ID A5021003825. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 1 paper

Papers 2

Editorial: Targeting Pancreatic Cancer: Strategies and Hopes. Co-author DOI 10.3389/fonc.2022.873682 ↗
Inhibition of Isoprenylcysteine Carboxylmethyltransferase Induces Cell-Cycle Arrest and Apoptosis through p21 and p21-Regulated BNIP3 Induction in Pancreatic C… Co-author DOI 10.1158/1535-7163.mct-16-0703 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Takatsugu Ishimoto · 1 shared paper, 2022 · strength 0.26
- Paper Editorial: Targeting Pancreatic Cancer: Strategies and Hopes. DOI 10.3389/fonc.2022.873682 ↗
Kuzhuvelil B. Harikumar · 1 shared paper, 2022 · strength 0.26
- Paper Editorial: Targeting Pancreatic Cancer: Strategies and Hopes. DOI 10.3389/fonc.2022.873682 ↗
Mei Wang · 1 shared paper, 2017 · strength 0.08
- Paper Inhibition of Isoprenylcysteine Carboxylmethyltransferase Induces Cell-Cycle Arrest and Apoptosis through p21 and p21-R… DOI 10.1158/1535-7163.mct-16-0703 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.